IntrinsicIntrinsic
← Scroll for more →

Financial Statements — UBYH

Balance Sheet

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Cash & Equivalents0.000.000.000.000.000.000.00--0.000.00--0.000.000.00
Total Assets0.01--------------------------
Accounts Payable0.010.010.00--0.010.03------------0.010.01
Total Current Liabilities0.160.130.100.080.070.05----0.050.05--0.040.030.02
Total Non-current Liabilities*0.00--------------------------
Total Liabilities*0.16--------------------------
Retained Earnings(14.37)(14.35)(14.32)(14.29)(14.29)(14.27)(14.21)(14.21)(14.21)(14.21)(14.18)(13.96)(13.95)(13.93)
Total Stockholder Equity(0.16)(0.13)(0.10)(0.08)(0.07)(0.05)(0.05)--(0.05)(0.05)--(0.04)(0.03)(0.01)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in thousands USD) (except per-share rows)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Selling, General & Admin20.7830.0224.067.7520.31--284.10----37.85220.467.4318.36
Total Operating Expenses20.7830.0224.067.7520.31--284.10----37.85220.467.4318.36
Operating Income(20.78)(30.01)(24.06)(7.75)(20.31)--(284.10)----(37.85)(220.46)(7.43)(18.36)
Pretax Income(20.78)(30.01)(24.06)(7.75)(20.31)--(284.10)----(37.85)(220.46)(7.43)(18.36)
Net Income(20.78)(30.01)(24.06)(7.75)(20.31)(52.72)0.000.000.00(37.85)(220.46)(7.43)(18.36)
Basic EPS0.00--0.00----------------0.000.00
Diluted EPS0.00--0.00----------------0.000.00
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2024Q3 2024Q2 2024Q1 2024
Operating Cash Flow(30.82)(22.04)(19.97)(17.81)(44.39)13.70(18.01)(7.43)(28.36)
Financing Cash Flow30.8222.0519.9717.8144.39(13.70)18.017.4328.36
← Scroll for more columns →